https://www.nasdaq.com/press-release/bellus-health-closes-us%24200-million-public-offering-of-common-shares-in-canada-and
https://www.nasdaq.com/press-release/bellus-health-announces-pricing-of-us%24200-million-public-offering-in-canada-and-the
https://www.nasdaq.com/press-release/bellus-health-announces-the-launch-of-a-public-offering-of-common-shares-in-canada-0
https://www.nasdaq.com/press-release/bellus-health-announces-positive-topline-results-from-its-phase-2b-soothe-trial-of
https://www.nasdaq.com/press-release/bellus-health-reports-third-quarter-2021-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-two-upcoming-healthcare-investor-conferences-2021-11
https://www.nasdaq.com/press-release/bellus-health-convenes-virtual-analyst-event-to-discuss-the-chronic-cough-landscape
https://www.nasdaq.com/press-release/bellus-health-announces-completion-of-patient-enrollment-in-soothe-phase-2b-trial-for
https://www.nasdaq.com/press-release/bellus-health-announces-positive-interim-analysis-from-the-phase-2b-soothe-trial-of
https://www.nasdaq.com/press-release/bellus-health-to-present-at-the-h.c.-wainwright-global-investment-conference-2021-09
https://www.nasdaq.com/press-release/bellus-health-to-report-additional-relief-data-in-an-oral-presentation-at-the
https://www.nasdaq.com/press-release/bellus-health-reports-second-quarter-2021-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-the-jefferies-virtual-healthcare-conference-2021-05
https://www.nasdaq.com/press-release/morganti-co.-p.l.c.-announces-the-filing-of-a-securities-class-action-on-behalf-of
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-the-2021-rbc-capital-markets-global-healthcare
https://www.nasdaq.com/press-release/bellus-health-reports-first-quarter-2021-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/bellus-health-to-present-at-the-american-thoracic-society-2021-international
https://www.nasdaq.com/press-release/bellus-health-to-present-at-the-bloom-burton-co.-healthcare-investor-conference-2021
https://www.nasdaq.com/press-release/blu-shareholder-filing-deadline%3a-bernstein-liebhard-llp-reminds-investors-of-the
https://www.nasdaq.com/press-release/notice-of-lead-plaintiff-deadline-for-shareholders-in-the-bellus-health-inc.-class
https://www.nasdaq.com/press-release/bellus-health-appoints-william-mezzanotte-md-mph-to-its-board-of-directors-2021-03-24
https://www.nasdaq.com/press-release/bellus-health-reports-year-2020-financial-results-and-business-highlights-2021-02-25
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-two-upcoming-healthcare-investor-conferences-2021-02
https://www.nasdaq.com/press-release/bellus-health-to-present-at-the-eleventh-international-virtual-cough-symposium-2021
https://www.nasdaq.com/press-release/bellus-health-establishes-at-the-market-facility-2020-12-23
https://www.nasdaq.com/press-release/bellus-health-announces-first-patient-dosed-in-its-phase-2-blueprint-trial-of-blu
https://www.nasdaq.com/press-release/bellus-health-announces-first-patient-dosed-in-its-phase-2b-soothe-trial-of-blu-5937
https://www.nasdaq.com/press-release/bellus-health-appoints-ramzi-benamar-as-chief-financial-officer-2020-12-07
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-the-evercore-isi-3rd-annual-virtual-healthconx
https://www.nasdaq.com/press-release/bellus-health-reports-third-quarter-2020-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-jefferies-virtual-london-healthcare-conference-2020
https://www.nasdaq.com/press-release/bellus-health-closes-us%2440-million-public-offering-of-common-shares-in-canada-and-the
https://www.nasdaq.com/press-release/bellus-health-announces-pricing-of-us%2435-million-public-offering-in-canada-and-the
https://www.nasdaq.com/press-release/bellus-health-announces-the-launch-of-a-public-offering-of-common-shares-in-canada
https://www.nasdaq.com/press-release/bellus-health-announces-design-for-its-phase-2b-trial-with-blu-5937-in-refractory
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-two-upcoming-healthcare-investor-conferences-2020-09
https://www.nasdaq.com/press-release/bellus-health-reports-second-quarter-2020-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/bellus-health-announces-topline-results-from-its-phase-2-relief-trial-of-blu-5937-for
https://www.nasdaq.com/press-release/bellus-health-to-participate-in-fireside-chat-at-the-jefferies-virtual-healthcare
https://www.nasdaq.com/press-release/bellus-health-reports-first-quarter-2020-financial-results-and-business-highlights
https://www.nasdaq.com/press-release/bellus-health-convenes-virtual-kol-meeting-to-discuss-the-state-of-chronic-cough
https://www.nasdaq.com/press-release/bellus-health-to-present-at-the-bofa-securities-virtual-health-care-conference-2020
https://www.nasdaq.com/press-release/bellus-health-announces-change-to-annual-and-special-shareholder-meeting-format-2020
https://www.nasdaq.com/press-release/bellus-health-announces-completion-of-dosing-in-phase-2-relief-trial-with-blu-5937
https://www.nasdaq.com/press-release/bellus-health-announces-transaction-to-acquire-remaining-intellectual-property-rights
https://www.nasdaq.com/press-release/bellus-health-announces-completion-of-enrollment-in-phase-2-relief-trial-of-blu-5937
https://www.nasdaq.com/press-release/bellus-health-reports-full-year-2019-financial-results-and-business-highlights-on-blu
https://www.nasdaq.com/press-release/bellus-health-to-present-at-two-upcoming-healthcare-investor-conferences-2020-02-20
